EGFR-targeted plasmonic magnetic nanoparticles suppress lung tumor growth by abrogating G2/M cell-cycle arrest and inducing DNA damage
Rajagopal Ramesh(The University of Texas MD Anderson Cancer Center), Jack A. Roth(The University of Texas MD Anderson Cancer Center)
Cited by 41
Related Papers
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
|Cancer Cell|2021|930
Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer
|JNCI Journal of the National Cancer Institute|1999|497
Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery.
|Circulation|1985|168
Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy
|Scientific Reports|2017|122